Concepedia

Differences in interleukin 1 (IL-1), IL-6, tumor necrosis factor and IL-1 receptor antagonist production by human monocytes stimulated with muramyl dipeptide (MDP) and its stearoyl derivative, romurtide

Katsuya Suzuki, Keiko U. Torii, Shigeaki Hida, Hidetoshi Hayashi, Yoshio Hiyama, Yasukazu Oomoto, Takemasa Takii, Taku Chiba, Kikuo Onozaki

Immunopharmacology · 1994 · 22 citations · 22 references

DOI

Concepts

References

22

There is more than one interleukin 1

Joost J. Oppenheim, Elizabeth J. Kovacs, Kouji Matsushima et al. · Immunology Today · 1986 · 1.2K citations

, , +9

Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives

Farielle Ellouz, Arlette Adam, R Ciorbaru et al. · Biochemical and Biophysical Research Communications · 1974 · 1K citations

, , +10

Interleukin-6 is a potent thrombopoietic factor in vivo in mice

Toshiyuki Ishibashi, Hideo Kimura, Yayoi Shikama et al. · Blood · 1989 · 422 citations · Full text

, , +12

Interleukin 1 is a radioprotector.

R Neta, S Douches, J J Oppenheim · The Journal of Immunology · 1986 · 376 citations · Full text

, , +17

Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist.

Edouard Vannier, Laurie C. Miller, Charles A. Dinarello · Proceedings of the National Academy of Sciences · 1992 · 320 citations · Full text

, , +12